Transforming growth factor beta (TGF-beta) is a protein that helps control functions in cells such as differentiation and proliferation. It works as an anti-proliferative factor during early stages of oncogenesis in epithelial cells. Abnormal amounts of TGF-beta can lead to the progression of some diseases and disorders including cancer, heart disease, autoimmune diseases, and Parkinson’s disease. TGF-beta 1, more specifically, plays a role in controlling the immune system in certain functions including wound healing. When TGF-beta 1 is initially secreted, most often by leukocytes, it is in a latent form that needs to be activated in order to carry out its functions. There are several factors that have been shown to contribute to the activation of TGF-beta 1, including plasmins and integrins in diseases such as pulmonary fibrosis. The activation of this protein most often results in the TGF-beta signaling cascade to commence, leading to the growth and proliferation of various cells.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Transforming Growth Factor Beta1 Activation below!
For more information on how to use Laverne, please read the How to Guide.
We have 566 products for the study of the Transforming Growth Factor Beta1 Activation Pathway that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.